Clinical Trial Update: Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of VE800 in combination with nivolumab has completed enrollment and posted results for selected advanced cancers. The study includes me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma
• Melanoma

Drugs mentioned

• OPDIVO (nivolumab)
• VE800

Snippet

Sponsor: Vedanta Biosciences, Inc. | Conditions: Metastatic Cancer, Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-08-29